Search results
Alembic Pharmaceuticals receives tentative US FDA approval for Ivosidenib Tablets, 250 mg - ET...
The Economic Times· 1 day agoIvosidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with a...
Endemic dengue may have helped stem severity of early COVID wave in India: study
The Hindu· 6 days agoCan the dengue virus beat the coronavirus and is it why the early wave of the pandemic in 2020...
Central Travancore a sitting duck for avian flu
The Hindu· 1 day agoIt was just another day for Abraham Ouseph, who had taken his ducks to the Vilakkupadam paddy polder for foraging as usual. Ouseph hails from...
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 2 days agoIf successful, this will be the first time that an NHS trust has the authorisation to market a drug...
A growing scourge of rare genetic diseases and why it matters for India
Financial Express· 4 days agoA peep into the human genomic makeup is no more the preserve of the well-heeled. Today, thanks to...
VB arrests patwari ‘taking bribe’
Hindustan Times· 2 days agoAn official spokesperson of the VB said the patwari was arrested on a complaint lodged by Jagjeet Singh, a resident of Dhakki village in Pathankot. After ...
Will your breast cancer come back? New blood test can predict with 100% accuracy. Here's all you...
Hindustan Times· 4 days agoAccording to the research, it states that this specific blood test uses advanced technologies to...
Feds prepare for bird flu jump to people with vaccines, tests
Washington State Standard· 2 days agoFederal health officials have commissioned Moderna to develop a vaccine to protect people from an...
8 Zika cases in Maharashtra, no need for panic: NIV director
Indian Express· 3 days agoZika virus is a vector-borne flavivirus transmitted by the bite of infected aedes mosquitoes- mainly...
US FDA declines to approve Rocket Pharma's immune disorder gene therapy - ET HealthWorld | Pharma
The Economic Times· 7 days agoLondon: Rocket Pharmaceuticals said on Friday the U.S. health regulator declined to approve its gene...
